91
Views
4
CrossRef citations to date
0
Altmetric
Original Research

PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve

, , , , , , , , , , , , & show all
Pages 375-384 | Published online: 28 Aug 2019

References

  • Johansson S, Rosengren A, Young K, Jennings E. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review. BMC Cardiovasc Disord. 2017;17:53. doi:10.1186/s12872-017-0482-928173750
  • Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010;96:1617–1621. doi:10.1136/hrt.2010.19880420801780
  • Task Force M; Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34(38):2949–3003. doi:10.1093/eurheartj/eht29623996286
  • Brainin P, Frestad D, Prescott E. The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: a systematic review and meta-analysis. Int J Cardiol. 2018;254:1–9. doi:10.1016/j.ijcard.2017.10.05229407076
  • Murthy VL, Naya M, Foster CR, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858–1868. doi:10.1161/CIRCULATIONAHA.112.12040222919001
  • Cortigiani L, Rigo F, Gherardi S, et al. Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. JACC. 2012;5:1079–1085. doi:10.1016/j.jcmg.2012.08.00723153906
  • Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215–2224. doi:10.1161/CIRCULATIONAHA.111.05042722007073
  • Gan LM, Svedlund S, Wittfeldt A, et al. Incremental value of transthoracic doppler echocardiography-assessed coronary flow reserve in patients with suspected myocardial ischemia undergoing myocardial perfusion scintigraphy. J Am Heart Assoc. 2017;6:e004875.28420647
  • Gan LM, Wikstrom J, Fritsche-Danielson R. Coronary flow reserve from mouse to man–from mechanistic understanding to future interventions. J Cardiovasc Transl Res. 2013;6:715–728. doi:10.1007/s12265-013-9497-523877202
  • Evangelista A, Flachskampf F, Lancellotti P, et al.. European association of echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr. 2008;9:438–448. doi:10.1093/ejechocard/jen17418579482
  • Wittfeldt A, Emanuelsson H, Brandrup-Wognsen G, et al. Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. J Am Coll Cardiol. 2013;61:723–727. doi:10.1016/j.jacc.2012.11.03223312702
  • Haraldsson I, Gan LM, Svedlund S, et al. Non-invasive evaluation of coronary flow reserve with transthoracic Doppler echocardiography predicts the presence of significant stenosis in coronary arteries. Int J Cardiol. 2014;176:294–297. doi:10.1016/j.ijcard.2014.06.07625049015
  • Kato S, Saito N, Kirigaya H, et al. Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction. J Am Heart Assoc. 2016;5:e002649.26908404
  • Kawata T, Daimon M, Hasegawa R, et al. Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease. Cardiovasc Diabetol. 2013;12:121. doi:10.1186/1475-2840-12-12123978254
  • van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16:219–242. doi:10.1177/096228020607446317621469
  • Rubin DB. Inference and Missing Data. Biometrika. 1976;63:581–590. doi:10.1093/biomet/63.3.581
  • Nakanishi K, Fukuda S, Shimada K, et al. Impaired coronary flow reserve as a marker of microvascular dysfunction to predict long-term cardiovascular outcomes, acute coronary syndrome and the development of heart failure. Circ J. 2012;76:1958–1964.22640984
  • Serruys PW, Di Mario C, Piek J, et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE study (Doppler endpoints balloon angioplasty trial Europe). Circulation. 1997;96:3369–3377. doi:10.1161/01.cir.96.10.33699396429
  • Cortigiani L, Rigo F, Gherardi S, et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol. 2007;50:1354–1361. doi:10.1016/j.jacc.2007.06.02717903635
  • Smits PC, Abdel-Wahab M, Neumann F-J, et al. Fractional flow reserve–guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234–1244. doi:10.1056/NEJMoa170106728317428
  • Dhawan SS, Corban MT, Nanjundappa RA, et al. Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma. Atherosclerosis. 2012;223:384–388. doi:10.1016/j.atherosclerosis.2012.05.03422766333